Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis.
Journal: Journal of medical economics
Published: March 13, 2026
Real-world romiplostim dosing, response and home administration in paediatric immune thrombocytopenia.
Journal: British journal of haematology
Published: February 09, 2026
Feasibility and outcomes of switching factor VIII therapies: post-hoc analysis of patients transitioning from older plasma-derived and first-generation recombinant factor VIII to newer third-generation recombinant factor VIII replacement therapies within the Takeda factor VIII portfolio.
Journal: Expert review of hematology
Published: January 21, 2026
Treatment Strategies and Outcomes in Pediatric Patients With Immune Thrombocytopenia Undergoing Surgical Procedures: A Multicenter Study.
Journal: Pediatric blood & cancer
Published: January 17, 2026
Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia.
Journal: Pediatric blood & cancer
Published: July 28, 2025
Increased percentages of circulating T follicular helper cells associate with disease subtype and activity in pediatric immune cytopenias.
Journal: Haematologica
Published: April 11, 2025
Hereditary thrombocytopenia with platelet sialic acid deficiency and mutations in the GNE genes.
Journal: Transfusion
Published: October 23, 2022
Patient-centered approach to managing factor XIII deficiency.
Journal: BMJ case reports
Published: September 17, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026